Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Big Tex House of Coin -- Ignore unavailable to you. Want to Upgrade?

To: MikeF8 who wrote (12296)	3/7/2000 9:41:00 AM
From: herry iball	Respond to of 19297

WASP: Chart looks very promising chart.bigcharts.com News from yesterday: OTC Financial Network Issues Research Report On Wasatch Pharmaceutical, Inc. MIDVALE, Utah--(BUSINESS WIRE)--March 6, 2000--Wasatch Pharmaceutical, Inc. (OTC BB:WASP - news), a leader in the research, development and distribution of dermatological treatments for skin disorders including acne and psoriasis, today announced that OTC Financial Network, a division of National Financial Communications Corp, has issued an in-depth analytic report on the Company, available online at www.otcfn.com/wasp/2page.html. The report is also available for reprint for individual investors, brokers, money managers, and institutional investors by calling 781/444-6100, ext. 11. ``After a decade and a half of research, Wasatch has developed a line of products and treatments for a wide variety of skin disorders that constitute a breakthrough in the field of dermatology,' stated OTC Financial Network President Geoffrey Eiten. ``The imminent release of these products and treatments on the open marketplace, combined with the Company's plan to establish a chain of treatment clinics nationwide, will drive its dramatic growth over the next 36 months.' Wasatch Pharmaceutical, Inc. is a leading research and development entity in the field of dermatology. The Company targets its products and treatments to a wide variety of specific dermatological disease areas, including cystic acne, psoriasis, eczema, and seborrhea.